JNT-517   Click here for help

GtoPdb Ligand ID: 12899

Synonyms: JNT517
Compound class: Synthetic organic
Comment: JNT-517 (Jnana Therapeutics) is an oral, allosteric inhibitor of SCL6A19-mediated phenylalanine reabsorption in the kidney. It is in clinical development for potential to treat phenylketonuria, an inherited metabolic disorder caused by phenylalanine hydroxylase (PAH) deficiency. The chemical structure shown here was revealed during the First Time Disclosures session at the ACS meeting in September 2023, and we picked it up from Drug Hunter. Jnana Therapeutics have a patent that claims small molecule SCL6A19 inhibitors (WO2023122267A2), but this structure doesn't appear in that patent [1].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 9
Topological polar surface area 87.9
Molecular weight 418.39
XLogP 1.41
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1C[C@H](CN(C1)C(=O)N)N(C2CC2)C(=O)NCC3=CC=C(C=C3F)OC(F)(F)F
Isomeric SMILES NC(=O)N1CCC[C@H](C1)N(C2CC2)C(=O)NCC3=CC=C(OC(F)(F)F)C=C3F
InChI InChI=1S/C18H22F4N4O3/c19-15-8-14(29-18(20,21)22)6-3-11(15)9-24-17(28)26(12-4-5-12)13-2-1-7-25(10-13)16(23)27/h3,6,8,12-13H,1-2,4-5,7,9-10H2,(H2,23,27)(H,24,28)/t13-/m1/s1
InChI Key FNRHWODWSBDOOY-CYBMUJFWSA-N
References
1. Brown DG, Muncipinto G, Zweig JE, Hollibaugh RA, Pullen N, Antalek MT, Nguyen LV, Malona JA. (2023)
Small molecule inhibitors of mammalian slc6a19 function.
Patent number: WO2023122267A2. Assignee: Jnana Therapeutics Inc.. Priority date: 22/12/2022. Publication date: 03/08/2023.